Fig. 1From: Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancersExpression of TRPM7 in breast cancer and normal tissues. In TCGA database, compared with GTEx (Genotype-Tissue Expression Rad), the expression of TRPM7 was lower in Basal like and Her2 + breast cancers. However, the expression of TRPM7 was higher in the Lumina A and Luminal B subtypesBack to article page